These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6093527)

  • 1. Abnormal laboratory test values during ceftriaxone therapy.
    Oakes M; MacDonald H; Wilson D
    Am J Med; 1984 Oct; 77(4C):89-96. PubMed ID: 6093527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical adverse effects during ceftriaxone therapy.
    Moskovitz BL
    Am J Med; 1984 Oct; 77(4C):84-8. PubMed ID: 6093526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV
    Am J Med; 1984 Oct; 77(4C):97-103. PubMed ID: 6093528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW; Snow RM
    Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone therapy of meningitis and serious infections.
    Steele RW
    Am J Med; 1984 Oct; 77(4C):50-3. PubMed ID: 6093519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined ceftriaxone and surgical therapy for osteomyelitis in hospital and outpatient settings.
    Eron LJ; Goldenberg RI; Poretz DM
    Am J Surg; 1984 Oct; 148(4A):1-4. PubMed ID: 6091473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profile of ceftriaxone in man.
    Patel IH; Kaplan SA
    Am J Med; 1984 Oct; 77(4C):17-25. PubMed ID: 6093513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment.
    Baumgartner JD; Glauser MP
    Arch Intern Med; 1983 Oct; 143(10):1868-73. PubMed ID: 6312914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone for once-a-day therapy of urinary tract infections.
    Childs SJ; Wells WG; Mirelman S
    Am J Med; 1984 Oct; 77(4C):73-6. PubMed ID: 6093524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twice daily ceftriaxone therapy for serious bacterial infections in children.
    Chonmaitree T; Congeni BL; Munoz J; Rakusan TA; Powell KR; Box QT
    J Antimicrob Chemother; 1984 May; 13(5):511-6. PubMed ID: 6330022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects.
    Saez-Llorens X; Violari A; Ndiweni D; Yogev R; Cashat M; Wiznia A; Chittick G; Harris J; Hinkle J; Blum MR; Adda N; Rousseau F;
    Pediatrics; 2008 Apr; 121(4):e827-35. PubMed ID: 18332076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose ceftriaxone versus multi-dose cefotaxime as short-term antimicrobial prophylaxis in urologic surgery. Preliminary results of a multicenter prospective randomized study.
    Periti P; Mazzei T; Lamanna S; Mini E
    Chemioterapia; 1984 Oct; 3(5):295-8. PubMed ID: 6099756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose ceftriaxone versus multiple-dose cefuroxime for antimicrobial chemoprophylaxis in pleuropulmonary surgery.
    Ilic N; Petricevic A; Kotarac S; Perisic R
    Panminerva Med; 1997 Sep; 39(3):240-3. PubMed ID: 9360431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose ceftriaxone versus multi-dose cefotaxime antimicrobial prophylaxis in gynecologic and obstetrical surgery. Preliminary results of a multicenter prospective randomized study.
    Periti P; Mazzei T; Lamanna S; Mini E
    Chemioterapia; 1984 Oct; 3(5):299-304. PubMed ID: 6099757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis.
    Ortiz-Alvarez O; Morishita K; Avery G; Green J; Petty RE; Tucker LB; Malleson PN; Cabral DA
    J Rheumatol; 2004 Dec; 31(12):2501-6. PubMed ID: 15570658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of complicated urinary tract infections with the long acting cephalosporin, ceftriaxone.
    Rothwell DL; Bremner DA; Taylor KM
    N Z Med J; 1983 May; 96(732):392-4. PubMed ID: 6302612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
    Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
    Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of three antimicrobial drugs protocol (Ceftriaxone, Gentamicin/Amikacin and Metronidazole) versus two antimicrobial drugs protocol (Ceftriaxone and Metronidazole) in cases of intra-abdominal sepsis.
    Khan S; Gupta DK; Khan DN
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):55-63. PubMed ID: 16401946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.